Riga, undefined

Oleg N Akifiev


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1984-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oleg N Akifiev: Innovator in Pharmaceutical Composition

Introduction

Oleg N Akifiev is a notable inventor based in Riga, Latvia, recognized for his contributions to the field of pharmaceutical compositions. With a total of 2 patents, Akifiev has made significant strides in developing innovative solutions for medical treatments.

Latest Patents

One of Akifiev's latest patents is an antibacterial pharmaceutical composition. This composition comprises potassium salt of N-[.beta.-(5'-nitrofuryl-2')-acrylidene]-1-aminohydantoin and basic magnesium carbonate, combined with a pharmaceutically suitable filler. The proposed composition boasts a broader spectrum of action and higher biological accessibility compared to other antibacterial compositions in the nitrofuran series. Additionally, it is considerably less toxic and provides a bacteriostatic effect that surpasses prior art compositions. Another significant patent focuses on a pharmaceutical composition for treating cardiovascular diseases, which includes 3-(2,2,2-trimethylhydrazinium) propionate dihydrate.

Career Highlights

Throughout his career, Oleg N Akifiev has worked with esteemed institutions such as the Institute of Organic Synthesis of the Latvian Academy of Sciences. His work has contributed to advancements in pharmaceutical research and development.

Collaborations

Akifiev has collaborated with notable colleagues, including Ivars Y Kalvinsh and Alexei V Vinogradov, further enhancing his research and innovation in the field.

Conclusion

Oleg N Akifiev's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative patents reflect a dedication to improving treatment options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…